E. Mari

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer

Armando Santoro, Alessandro Comandone, Lorenza Rimassa et al. · Annals of Oncology · 2008 · 55 citations · Full text

Phase Ii, Gastrointestinal Oncology, Medicine +7

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

Stefano Cascinu, Rossana Berardi, Stefania Salvagni et al. · British Journal of Cancer · 2007 · 45 citations · Full text

Tumor Biology, Biological Analysis, Gene Amplification +15

Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines

Roberta Alfieri, Maricla Galetti, Stefano Tramonti et al. · Molecular Cancer · 2011 · 44 citations · Full text

Patterns of Care of an Italian Diabetic Population

Antonio Nicolucci, N. Scorpiglione, Maurizio Belfiglio et al. · Diabetic Medicine · 1997 · 28 citations · Full text